Drug – bio-affecting and body treating compositions – In vivo diagnosis or in vivo testing – Ultrasound contrast agent
Patent
1997-10-16
2000-07-04
Hollinden, Gary E.
Drug, bio-affecting and body treating compositions
In vivo diagnosis or in vivo testing
Ultrasound contrast agent
A61B 813
Patent
active
060834846
ABSTRACT:
Microparticles useful for enhancing the ultrasound image of a tissue or organ consist of liquid and/or gas core material which is encapsulated by a biocompatible, tanned protein shell. These stabilized microparticles are useful as ultrasonic imaging agents, and are additionally useful in the further production of functionalized microparticles for in vivo imaging. In particular, targeting molecules such as antibodies or other ligands can be attached to the strengthened exterior surface of the stabilized microparticles to impart target-specificity to the microparticles. The targeting molecules may also provide hydrophilicity to the exterior surface, thus increasing the recirculation time of the microparticles. The targeting molecules may be attached directly to the exterior surface of the microparticles, or they may be attached via a bifunctional spacer arm, which may itself be hydrophilic. The target-specific microparticles are injected intravenously, allowed to accumulate at the target site, and used to enhance the ultrasound image of a target tissue or organ.
REFERENCES:
patent: 4718433 (1988-01-01), Feinstein
patent: 4774958 (1988-10-01), Feinstein
patent: 4957656 (1990-09-01), Cerny et al.
patent: 5149543 (1992-09-01), Cohen et al.
patent: 5216130 (1993-06-01), Line et al.
patent: 5225282 (1993-07-01), Chagnon et al.
patent: 5308701 (1994-05-01), Cohen et al.
patent: 5364612 (1994-11-01), Goldenberg
patent: 5409688 (1995-04-01), Quay
patent: 5413774 (1995-05-01), Schneider et al.
patent: 5505932 (1996-04-01), Grinstaff et al.
patent: 5562099 (1996-10-01), Cohen et al.
Lasic et al., Sterically stabilized liposomes: A hypothesis on the molecular orgin of the extended circulation times: Biochim. Biophys. Acta (1991) 1070:187-192.
Beuth et al., "Inhibition of liver metastasis in mice by blocking hepatocyte lectins with arabinogalactan infusions and D-galactose" Cancer Res. Clin. Oncol. (1987) 113:51-55.
Wigglesworth, J. Insect Physiol., 36(5):307-314 (1990) abstract only.
Grinstaff, M.W. and Suslick, K.S., "Proteinaceous Microspheres" ACS Symposium Series 493:218-226 (1992).
Grinstaff, M.W. and Suslick, K.S., "Air-Filled Proteinaceous Microbubbles: Synthesis of an Echo-Contrast Agent" Proc. Natl. Acad. Sci. USA 88(17):7708-7710 (1991).
Laakso et al., "Acrylic Microspheres in vivo. X. Elimination of Circulating Cells by Active Targeting Using Specific Monoclonal Antibodies Bound to Microparticles" Life Sciences 38(2):183-190 (1986).
Longo et al., "Preparation of Hydrophilic Albumin Microspheres Using Polymeric Dispersing Agents" J. Pharm. Sci. 71(12):1323-1328 (1982).
Ophir and Parker, "Contrast agents in diagnostic ultrasound" Ultrasound in Med. and Biol. (1989) 15(4):319-333.
deJong et al. "Quantification of transpulmonary echocontrast effects" Ultrasound in Med. Biol. (1993) 19(4):279-288.
Ashwell and Morell, "The role of surface carbohydrates in the hepatic recognition and transport of circulating glycoproteins" Adv. Enzymol. (Meister, ed, Interscience Publication 1974) 41:99-128.
Ashwell and Harford, "Carbohydrate-specific receptors of the liver" Ann. Rev. Biochem. (1982) 51:531-554.
Josephson et al., "A functionalized superparamagnetic iron oxide colloid as a receptor directed MR contrast agent" Mag. Res. Imag. (1990) 8:637-646.
Heidemann, "Leather" Ullmann's Encyclopedia of Industrial Chemistry, 5.sup.th ed., Elvers et al. eds., A15:259-274 (VCH Publishers, New York 1990).
Wang et al., "A monoclonal antobody reacting with platelets for monitoring thrombolysis" Nucl. Med. Biol. (1991) 18(3):275-280.
Bini et al., "Identification and distribution of fibrinogen, fibrin, and fibrin(ogen) degradation products in atherosclerosis" Arteriosclerosis (1989) 9(1):109-121.
Knight, "Imaging thrombi with radiolabelled anti-fibrin monoclonal antibodies" Nucl. Med. Comm. (1988) 9:823-829.
Milenic et al., "Construction binding properties, metabolism, and tumor targeting of a single chain Fv derived from the pancarcinoma monoclonal antibody CC49" Cancer Res. (1991) 51:6363-6371.
Goldenberg and Larson, "Radioimmunodetection in cancer identification" J. Nucl Med. (1992) 33(5):803-814.
Ojima et al., "Antithrombotic agents: From RGD to peptide mimetics" Bioorganic & Med. Chem. (1995) 3(4):337-360.
Golec Brent Lee
Lohrmann Rolf
Axford Laurie A.
Hollinden Gary E.
Molecular Biosystems, Inc.
LandOfFree
Microparticles stabilized by polynuclear chromium complexes and does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Microparticles stabilized by polynuclear chromium complexes and , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Microparticles stabilized by polynuclear chromium complexes and will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1483258